EECP® was FDA approved in 1995 for the treatment of coronary artery disease and angina, cardiogenic shock, and for use during a heart attack. In 2002, the FDA approved EECP® as a treatment for congestive heart failure. EECP® has undergone clinical trials at leading universities around the nation and been subject to over a hundred scientific studies published in the most prestigious medical journals throughout the world.
Do you have questions about the EECP® process? We have taken the time to answer many of the common questions regarding EECP® on our F.A.Q. page. Please click to learn more
The heart can be complicated to understand, along with the causes of angina and its affects. If you have questions about the heart or angina, please click to learn more